OPCH Stock Forecast 2025-2026
Distance to OPCH Price Targets
OPCH Price Momentum
10 Quality Stocks Worth Considering Now
Researching Option Care (OPCH) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on OPCH and similar high-potential opportunities.
Latest OPCH Stock Price Targets & Analyst Predictions
Based on our analysis of 10 Wall Street analysts, OPCH has a bullish consensus with a median price target of $38.00 (ranging from $33.00 to $41.00). The overall analyst rating is Strong Buy (8.6/10). Currently trading at $35.03, the median forecast implies a 8.5% upside. This outlook is supported by 8 Buy, 2 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Lisa Gill at JP Morgan, projecting a 17.0% upside. Conversely, the most conservative target is provided by Michael Petusky at Barrington Research, suggesting a 5.8% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
OPCH Analyst Ratings
OPCH Price Target Range
Latest OPCH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for OPCH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 6, 2025 | JP Morgan | Lisa Gill | Overweight | Maintains | $41.00 |
| Feb 27, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $38.00 |
| Jan 24, 2025 | JP Morgan | Lisa Gill | Overweight | Maintains | $40.00 |
| Jan 23, 2025 | Jefferies | Brian Tanquilut | Buy | Upgrade | $35.00 |
| Jan 14, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $33.00 |
| Jan 10, 2025 | JMP Securities | Constantine Davides | Market Outperform | Reiterates | $30.00 |
| Dec 5, 2024 | UBS | A.J. Rice | Neutral | Initiates | $26.00 |
| Nov 5, 2024 | Goldman Sachs | Jamie Perse | Neutral | Downgrade | $27.00 |
| Nov 1, 2024 | Truist Securities | David Macdonald | Buy | Maintains | $34.00 |
| Oct 31, 2024 | Jefferies | Brian Tanquilut | Hold | Downgrade | $26.00 |
| Oct 31, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $32.00 |
| Oct 23, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $40.00 |
| Sep 30, 2024 | JMP Securities | Constantine Davides | Market Outperform | Maintains | $37.00 |
| Aug 1, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $40.00 |
| Jul 25, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $38.00 |
| Jul 16, 2024 | JMP Securities | Constantine Davides | Market Outperform | Initiates | $36.00 |
| Apr 24, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $38.00 |
| Mar 4, 2024 | Jefferies | Brian Tanquilut | Buy | Maintains | $38.00 |
| Feb 23, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $38.00 |
| Oct 26, 2023 | Barrington Research | Michael Petusky | Outperform | Maintains | $35.00 |
Option Care Health Inc. (OPCH) Competitors
The following stocks are similar to Option Care based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Option Care Health Inc. (OPCH) Financial Data
Option Care Health Inc. has a market capitalization of $5.79B with a P/E ratio of 28.5x. The company generates $5.00B in trailing twelve-month revenue with a 4.2% profit margin.
Revenue growth is +19.7% quarter-over-quarter, while maintaining an operating margin of +6.5% and return on equity of +15.0%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Option Care Health Inc. (OPCH) Business Model
About Option Care Health Inc.
Provides infusion therapy and related healthcare services.
The company operates a network of facilities and offers home-based services along with care management programs to deliver infusion therapy for critical illnesses. It generates revenue through the provision of specialized treatment plans that cater to individual patient needs, focusing on chronic conditions and immune disorders.
Option Care Health is positioned in the growing specialty medications market and plays a crucial role in enhancing patient outcomes by integrating care between hospitals and home environments. Its commitment to clinical expertise and personalized care plans makes it a significant player in the healthcare sector.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
6,015
CEO
Mr. John C. Rademacher
Country
United States
IPO Year
1996
Website
www.optioncarehealth.comOption Care Health Inc. (OPCH) Latest News & Analysis
Option Care Health to Announce First Quarter 2025 Financial Results and Host Conference Call
2 days agoOption Care Health Inc. (NASDAQ: OPCH) will release its Q1 2025 results on April 29, 2025, before market open, followed by a conference call at 8:30 a.m. E.T.
Option Care Health's upcoming earnings report and conference call could significantly impact its stock price, influencing investor sentiment and strategies based on performance expectations.
Option Care (OPCH) shows strong financial growth potential, indicating it may outperform the market.
Option Care's above-average financial growth suggests strong future performance, potentially leading to higher returns and increased investor interest in the stock.
Option Care (OPCH) has reached a 52-week high. Investors are assessing the company's fundamentals for potential future gains.
Option Care's 52-week high indicates strong market performance, prompting investors to assess fundamentals for potential continued growth and profitability.
Investors in Medical - Outpatient and Home Healthcare stocks are comparing Option Care (OPCH) and Chemed (CHE) for potential value opportunities.
The comparison of Option Care and Chemed highlights potential investment opportunities in the outpatient and home healthcare sector, indicating possible shifts in value and performance.
Option Care (OPCH) is expected to deliver strong returns due to its robust growth potential.
Option Care's strong growth potential indicates likely profitability and value appreciation, making it a compelling investment opportunity in the healthcare sector.
GILD, OPCH, and AVAH have shown strong performance with a consistent history of earnings surprises, indicating their financial resilience.
GILD, OPCH, and AVAH's strong earnings surprises signal potential for continued growth, indicating robust performance that could positively impact stock valuations and investor confidence.
Frequently Asked Questions About OPCH Stock
What is Option Care Health Inc.'s (OPCH) stock forecast for 2025?
Based on our analysis of 10 Wall Street analysts, Option Care Health Inc. (OPCH) has a median price target of $38.00. The highest price target is $41.00 and the lowest is $33.00.
Is OPCH stock a good investment in 2025?
According to current analyst ratings, OPCH has 8 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $35.03. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for OPCH stock?
Wall Street analysts predict OPCH stock could reach $38.00 in the next 12 months. This represents a 8.5% increase from the current price of $35.03. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Option Care Health Inc.'s business model?
The company operates a network of facilities and offers home-based services along with care management programs to deliver infusion therapy for critical illnesses. It generates revenue through the provision of specialized treatment plans that cater to individual patient needs, focusing on chronic conditions and immune disorders.
What is the highest forecasted price for OPCH Option Care Health Inc.?
The highest price target for OPCH is $41.00 from Lisa Gill at JP Morgan, which represents a 17.0% increase from the current price of $35.03.
What is the lowest forecasted price for OPCH Option Care Health Inc.?
The lowest price target for OPCH is $33.00 from Michael Petusky at Barrington Research, which represents a -5.8% decrease from the current price of $35.03.
What is the overall OPCH consensus from analysts for Option Care Health Inc.?
The overall analyst consensus for OPCH is bullish. Out of 10 Wall Street analysts, 8 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $38.00.
How accurate are OPCH stock price projections?
Stock price projections, including those for Option Care Health Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
